BiotechTube
Magle Chemoswed

Magle Chemoswed

Malmö, Sweden· Est.
maglechemoswed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Magle Chemoswed is a private, revenue-generating CDMO founded in 2003, specializing in supporting pharmaceutical and medical device innovators from development to commercial manufacturing. The company operates a flexible, multi-suite cGMP facility and offers a broad service portfolio, including analytical development, process development, solid-state science, and specialized manufacturing for complex dosage forms like lyophilized and inhalation products. It positions itself as a strategic partner, leveraging over a decade of experience to help clients navigate regulatory challenges and improve success rates in drug development.

Small MoleculesDrug Delivery

Technology Platform

Integrated CDMO services with specialized expertise in analytical development, process development, solid-state science, and manufacturing of complex dosage forms (lyophilized, inhaled, sterile fill-finish).

Opportunities

Growing demand for outsourced lyophilization services driven by the increase in biologic and complex small molecule drugs.
Expansion of the inhalation drug delivery market for both respiratory and systemic diseases creates a need for specialized CDMO expertise.
The trend among biotech companies to virtualize operations fuels demand for full-service, integrated development and manufacturing partners.

Risk Factors

Revenue is highly dependent on the clinical and commercial success of client programs, which can be unpredictable.
Intense competition from larger global CDMOs and smaller niche players pressures pricing and service differentiation.
Significant regulatory risk associated with cGMP manufacturing; any compliance failure could severely damage reputation and business viability.

Competitive Landscape

Magle Chemoswed competes in a fragmented global CDMO market. It faces competition from large, full-service players like Lonza, Catalent, and Recipharm, as well as from smaller, specialized CDMOs focusing on specific technologies like lyophilization or inhalation. Its competitive differentiation lies in its integrated service offering, specialized expertise in complex formulations, and its position as a mid-sized, flexible European partner.

More companies in Sweden →